Trial intelligence / Profile preview

Conservative versus active management of the third stage of labour in physiological childbirth

2008-002031-32Phase 3Active

Sponsor
Fondazione IRCCS San Gerardo dei Tintori
Start
May 2008
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of oxytocin and methylergometrine in postpartum hemorrhage (PPH) (2 arms), sponsored by Fondazione IRCCS San Gerardo dei Tintori. Primary endpoints: Postpartum haemorrhage, Severe postpartum haemorrhage and 1 more. Started May 2008; status: active.

02

Drugs

oxytocinmethylergometrine
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on 2008-002031-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002031-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call